Filing Details

Accession Number:
0001225208-13-013426
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-29 15:34:48
Reporting Period:
2013-05-23
Filing Date:
2013-05-29
Accepted Time:
2013-05-29 15:34:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
105770 West Pharmaceutical Services Inc WST Fabricated Rubber Products, Nec (3060) 231210010
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213306 Jr E Donald Morel 530 Herman O. West Drive
Exton PA 19341
Chair Of The Board & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-23 100,825 $41.70 603,993 No 4 M Direct
Common Stock Acquisiton 2013-05-23 96,576 $44.97 700,569 No 4 M Direct
Common Stock Disposition 2013-05-23 79,142 $67.61 621,427 No 4 F Direct
Common Stock Disposition 2013-05-23 79,995 $67.61 541,432 No 4 F Direct
Common Stock Disposition 2013-05-28 5,000 $68.04 536,432 No 4 S Direct
Common Stock Disposition 2013-05-28 5,000 $67.70 531,432 No 4 S Direct
Common Stock Acquisiton 2013-05-24 19 $67.38 20,527 No 4 A Indirect Non-Qualified Deferred Compensation Plan
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 A Indirect Non-Qualified Deferred Compensation Plan
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-23 100,825 $41.70 100,825 $41.70
Common Stock Stock Option (Right to Buy) Disposition 2013-05-23 96,576 $44.97 96,576 $44.97
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-02-26 2018-02-26 No 4 M Direct
0 2008-02-27 2018-02-27 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,336 Indirect By Savings Plan
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.48 to $68.30, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in foonotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.45 to $67.98, inclusive.